Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

Coronary surgery - keeping the way clear

20.09.2006
EUREKA project E! 3147 DRUG ELUTING STENT has developed a new generation of stent – a wire mesh tube.

This medical device keeps the coronary artery open while controlling the dose of medication and preventing blockage and excessive scaring. Coating the stent in biodegradable polymer containing the exact dose of medication ensures its total release and avoids potentially toxic drug retention. With heart disease and blocked coronary arteries among the major killers in the western world, this project hopes to pave the way for more precise drug delivery and increase success levels in heart surgery.

Ensuring blood supply to the heart, through the coronary artery, is essential to keep it working. However, the coronary artery is particularly prone to narrowing, causing a restricted blood flow and leading to angina or heart attacks. By inserting a wire mesh tube collapsed to a narrow diameter (the stent) into the narrow part of the artery, and inflating a balloon catheter inside, the artery is successfully held open. This procedure often causes damage to the artery wall; scar tissue forms around the stent and blocks the artery. The current technology consists in coating the stent with a biodegradable polymer bound with a drug to control this unwanted cell growth.

Less drug needed

The major problem with current drug eluting stents is that 85% of the drug, which is very toxic, remains in the coronary vessel for the rest of the patient’s life because it is bound in the polymer. To remedy this problem, the participants in the project developed a bio-absorbable polymer which is completely absorbed after about three weeks. This means it is possible to use a much smaller dose of drug, allowing for complete assimilation and leaving none unused in the stent. Blue Medical, a project participant from the Netherlands, has developed the optimum biopolymer and two drugs which will regulate excessive cell growth with much lower toxicity than is currently needed. Extensive testing has led to creating a uniform, reproducible and accurate biopolymer coating for the metal stent.

Blue Medical Devices focused on the drugs development, their interaction with the polymer and designing and validating the dosage as well as the elution rates and determining the effect of bio-absorption. Their partner, Creganna Medical Devices from Ireland, developed the process of applying the biodegradable polymer to the metal surface of the stent, with or without a drug component.

Both partners foresee a strong future for the product, which should be available in mid-2007. The projected market could reach 30% of the total stent market outside the US; worth €800m. Blue Medical has increased its workforce from 30 to 50 in two years and expects to employ 150 people by 2008. “As well as substantial financial benefit, participating in a EUREKA project has given the project a much higher profile and status, enabling strong international working relationships to be developed,” believes Ronald Horvers, project coordinator at Blue Medical Devices.

Sally Horspool | alfa
Further information:
http://www.eureka.be/drugelutingstent

More articles from Health and Medicine:

nachricht Penn vet research identifies new target for taming Ebola
12.01.2017 | University of Pennsylvania

nachricht The strange double life of Dab2
10.01.2017 | University of Miami Miller School of Medicine

All articles from Health and Medicine >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Designing Architecture with Solar Building Envelopes

Among the general public, solar thermal energy is currently associated with dark blue, rectangular collectors on building roofs. Technologies are needed for aesthetically high quality architecture which offer the architect more room for manoeuvre when it comes to low- and plus-energy buildings. With the “ArKol” project, researchers at Fraunhofer ISE together with partners are currently developing two façade collectors for solar thermal energy generation, which permit a high degree of design flexibility: a strip collector for opaque façade sections and a solar thermal blind for transparent sections. The current state of the two developments will be presented at the BAU 2017 trade fair.

As part of the “ArKol – development of architecturally highly integrated façade collectors with heat pipes” project, Fraunhofer ISE together with its partners...

Im Focus: How to inflate a hardened concrete shell with a weight of 80 t

At TU Wien, an alternative for resource intensive formwork for the construction of concrete domes was developed. It is now used in a test dome for the Austrian Federal Railways Infrastructure (ÖBB Infrastruktur).

Concrete shells are efficient structures, but not very resource efficient. The formwork for the construction of concrete domes alone requires a high amount of...

Im Focus: Bacterial Pac Man molecule snaps at sugar

Many pathogens use certain sugar compounds from their host to help conceal themselves against the immune system. Scientists at the University of Bonn have now, in cooperation with researchers at the University of York in the United Kingdom, analyzed the dynamics of a bacterial molecule that is involved in this process. They demonstrate that the protein grabs onto the sugar molecule with a Pac Man-like chewing motion and holds it until it can be used. Their results could help design therapeutics that could make the protein poorer at grabbing and holding and hence compromise the pathogen in the host. The study has now been published in “Biophysical Journal”.

The cells of the mouth, nose and intestinal mucosa produce large quantities of a chemical called sialic acid. Many bacteria possess a special transport system...

Im Focus: Newly proposed reference datasets improve weather satellite data quality

UMD, NOAA collaboration demonstrates suitability of in-orbit datasets for weather satellite calibration

"Traffic and weather, together on the hour!" blasts your local radio station, while your smartphone knows the weather halfway across the world. A network of...

Im Focus: Repairing defects in fiber-reinforced plastics more efficiently

Fiber-reinforced plastics (FRP) are frequently used in the aeronautic and automobile industry. However, the repair of workpieces made of these composite materials is often less profitable than exchanging the part. In order to increase the lifetime of FRP parts and to make them more eco-efficient, the Laser Zentrum Hannover e.V. (LZH) and the Apodius GmbH want to combine a new measuring device for fiber layer orientation with an innovative laser-based repair process.

Defects in FRP pieces may be production or operation-related. Whether or not repair is cost-effective depends on the geometry of the defective area, the tools...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

Event News

12V, 48V, high-voltage – trends in E/E automotive architecture

10.01.2017 | Event News

2nd Conference on Non-Textual Information on 10 and 11 May 2017 in Hannover

09.01.2017 | Event News

Nothing will happen without batteries making it happen!

05.01.2017 | Event News

 
Latest News

Multiregional brain on a chip

16.01.2017 | Power and Electrical Engineering

New technology enables 5-D imaging in live animals, humans

16.01.2017 | Information Technology

Researchers develop environmentally friendly soy air filter

16.01.2017 | Power and Electrical Engineering

VideoLinks
B2B-VideoLinks
More VideoLinks >>>